Help us: Donate
Follow us on:
Γ—

Menu

Back

Combining Epigenetic and Imaging Biomarkers

GrimAge can be even more powerful when combined with AI image analysis.

Brain ImageBrain Image

Cardiologists, epidemiologists, and other researchers publishing in Aging have discovered that epigenetic aging and brain scans can be combined to accurately predict cognitive decline.

Two entirely different measurements

The ongoing CARDIA study was started in 1985 to monitor coronary artery risk development in young adults (who are no longer young). This large cohort has been repeatedly analyzed with multiple metrics, and this study took an interest in two measurements of epigenetic aging (taken in 2000 and 2005) along with two brain scans done in 2010 and 2015.

Fortunately, it is possible to use modern epigenetic analyses on older epigenetic data. While other clocks were also examined, the researchers focused most prominently on the well-known GrimAge, a predictor of all-cause mortality that has also been found to be associated with brain health in previous research [1].

The researchers also used an entirely different biomarker, Spatial Pattern of Atrophy for Recognition of Brain Age (SPARE-BA), which is a machine learning algorithm that uses imaging to detect brain deterioriation. As expected, this marker is associated with verbal fluency and attention problems [2].

When used to measure the acceleration of biological aging compared to chronological aging, these biomarkers are termed GrimAA and SPARE-BAA. Despite being associated with brain aging, these two biomarkers are not strongly correlated with each other, and this surprising finding led the researchers of this study to combine these two biomarkers into a unified analysis.

To measure cognition, the researchers chose the well-known Stroop test, which uses words in different colors than the words represent, the RAVLT long-delay recall test, and the Digit Symbol Substitution Test (DSST), which maps numbers to symbols.

Each marker is already powerful

Analyzing GrimAA findings compared to cognitive decline, the researchers found that the 2005 GrimAge results were strongly associated with the 2010 cognitive testing results and that the 2000 GrimAge results were, interestingly, even more strongly associated with the 2015 cognitive testing on both the Stroop and DSST cognitive biomarkers.

Similarly, the 2010 SPARE-BAA results were able to significantly predict 2015 measurements on Stroop and DSST, and cross-sectional analyses also significantly correlated SPARE-BAA to cognitive decline, particularly the 2015 results.

Combining the 2005 GrimAA results and the 2015 SPARE-BAA results yielded the best measurement that the researchers were able to find. Other combinations offered no benefit over GrimAge alone.

Conclusion

The researchers make a number of conclusions related to epigenetic aging and physical brain aging. Importantly, they point out that changes to brain synapses are governed by epigenetic alterations [3], which can explain a direct association between GrimAge and the cognitive results. Other potential correlations, such as inflammation, were also suspected.

While the CARDIA study used a large and wide-ranging cohort, the researchers note that epigenetic measurements were not taken at younger ages and that unmeasured cofactors might have biased the results, a common concern for longitudinal studies such as this one. Despite these potential issues, however, this study inspires confidence that it may be possible to develop combined biomarkers that examine both epigenetics and physical morphology in order to get a better picture of aging.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Rejuvenation Roundup May 2023

This year, May brought us a shower of research, interviews, and insights into the present and future of rejuvenation biotechnology....

Dietary Magnesium in Dementia Prevention

Researchers publishing in the European Journal of Nutrition looked into magnesium as a possible candidate for preventing dementia, focusing on...

Glycine and Cysteine Combo Rescues Cognitive Decline in Mice

Scientists publishing in Antioxidants have reported that increasing glutathione levels with GlyNAC, a supplement that combines glycine and cysteine, significantly...

Vitalik Buterin Exclusive Interview: Longevity, AI and More

Vitalik Buterin holding Zuzu, the puppy rescued by people of Zuzalu. Photo: Michelle Lai Don’t try finding Zuzalu on a...

Literature

[1] Hillary, R. F., Stevenson, A. J., Cox, S. R., McCartney, D. L., Harris, S. E., Seeboth, A., … & Marioni, R. E. (2021). An epigenetic predictor of death captures multi-modal measures of brain health. Molecular psychiatry, 26(8), 3806-3816.

[2] Eavani, H., Habes, M., Satterthwaite, T. D., An, Y., Hsieh, M. K., Honnorat, N., … & Davatzikos, C. (2018). Heterogeneity of structural and functional imaging patterns of advanced brain aging revealed via machine learning methods. Neurobiology of aging, 71, 41-50.

[3] Barter, J. D., & Foster, T. C. (2018). Aging in the brain: new roles of epigenetics in cognitive decline. The Neuroscientist, 24(5), 516-525.

About the author
Josh Conway

Josh Conway

Josh is a professional editor and is responsible for editing our articles before they become available to the public as well as moderating our Discord server. He is also a programmer, long-time supporter of anti-aging medicine, and avid player of the strange game called β€œreal life.” Living in the center of the northern prairie, Josh enjoys long bike rides before the blizzards hit.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.